Evidence map›Paper›PMID 40561131›Full record

ArticlePLOS global public health2025

Use of minimally invasive tissue sampling to determine the contribution of diarrheal diseases to under-five mortality and associated co-morbidities and co-infections in children with fatal diarrheal diseases in Africa and Bangladesh.

Portia Chipo Mutevedzi, Zachary J Madewell, Karen L Kotloff, Quique Bassat, Percina Joao Chirinda, Anelsio C A Cossa, Elisio G Xerinda, Victor Akelo, Paul K Mitei, Elizabeth Oele and 27 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Portia Chipo MutevedziEmory Global Health Institute, Emory University, Atlanta, Georgia, United States of America.
Zachary J MadewellGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-5667-9660
Karen L KotloffDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0003-1808-6431
Quique BassatISGlobal-Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-0875-7596
Percina Joao ChirindaCentro de Investigação em Saúde de Manhiça-CISM, Maputo, Mozambique.ORCID https://orcid.org/0000-0002-2649-1034
Anelsio C A CossaCentro de Investigação em Saúde de Manhiça-CISM, Maputo, Mozambique.
Elisio G XerindaCentro de Investigação em Saúde de Manhiça-CISM, Maputo, Mozambique.
Victor AkeloKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Paul K MiteiKisumu East District Hospital, Kisumu, Kenya.
Elizabeth OeleKisumu County Department of Health, Kisumu, Kenya.ORCID https://orcid.org/0000-0001-6317-1518
Richard OmoreKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Dickens OnyangoKisumu County Department of Health, Kisumu, Kenya.ORCID https://orcid.org/0000-0002-1634-0531
Joseph BanguraMinistry of Health and Sanitation, Freetown, Sierra Leone.
Ronita LukeMinistry of Health and Sanitation, Freetown, Sierra Leone.
Andrew MoserayDepartment of Public Health, School of Community Health Sciences, Njala University Bo Campus, Bo City, Sierra Leone.
Ikechukwu Udo OgbuanuCrown Agents, Freetown, Sierra Leone.
Tom SesayDepartment of Public Health, School of Community Health Sciences, Njala University Bo Campus, Bo City, Sierra Leone.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID https://orcid.org/0000-0003-0341-2329
Temesgen Teferi LibeCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID https://orcid.org/0000-0003-4452-5573
Lola MadridCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Melisachew M YeshiDepartment of Pathology, Ayder Referral Hospital, Mekelle, Ethiopia.
J Anthony G ScottDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0001-7533-5006
Nelesh P GovenderMycology Reference Unit, National Institute for Communicable Diseases, Johannesburg, South Africa.
Sanjay G LalaDepartment of Paediatrics & Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0001-9964-513X
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Sana MahtabSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Adama Mamby KeitaCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Doh SanogoCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Samba O SowCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Milagritos D TapiaDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Shams El ArifeenInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
Emily S GurleyInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
Beth A Tippett BarrNyanja Health Research Institute, Salima, Malawi.
Cynthia G WhitneyEmory Global Health Institute, Emory University, Atlanta, Georgia, United States of America.
Dianna M BlauGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-1253-198X
Inacio MandomandoISGlobal-Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
CHAMPS Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving the Sustainable Development Goal of reducing child mortality to <25 deaths per 1000 live births by 2030 requires strategies to prevent diarrheal disease-related morbidity and mortality. Accurate etiological diagnosis is essential. This study used postmortem diagnostics to investigate the contribution of diarrhea to under-5 mortality and examine co-morbidities and co-infections in Africa and South Asia. Child Health and Mortality Prevention Surveillance (CHAMPS) generates data on child deaths through minimally invasive tissue sampling, clinical record review, and verbal autopsies. Multidisciplinary panels assign cause(s) of death using WHO International Classification of Diseases. This analysis included deaths among children aged 1-59 months enrolled from 18 December 2016-31 December 2023 across six African sites (Ethiopia, Mali, Kenya, Sierra Leone, Mozambique, South Africa) and Bangladesh. Of 1517 deaths assessed, diarrhea was in the causal pathway in 240 (15.8%). The proportion of diarrhea-related deaths was highest in Ethiopia (41.0%, 34/83), followed by Bangladesh, (30.0%, 3/10), Mozambique (21.7%, 56/258), Mali (17.5%, 18/103), Kenya (13.9%, 51/366), Sierra Leone (12.8%, 46/358), and South Africa (9.4%, 32/339). Diarrhea was underlying cause in 44.2% (106/240) of cases and immediate/antecedent cause in 58.3% (140/240), with some deaths involving multiple roles in the causal chain. When diarrhea was underlying cause, sepsis (33.0%) and lower respiratory infections (25.5%) were common downstream conditions; when an antecedent/immediate cause, leading underlying causes were malnutrition (64.3%) and HIV (13.6%). No pathogen was identified in 49.6% (119/240) of diarrhea-related deaths; among these, diarrhea was underlying cause in 42.9%. Among the 121 pathogen-attributed deaths, the most frequent were EAEC (34.7%), typical EPEC (15.7%), Shigella/EIEC (14.0%), ST-ETEC (12.4%), rotavirus (26.4%), and adenovirus (non-40/41: 19.0%; 40/41: 5.0%). These pathogens were frequently identified as co-infections. Diarrheal disease accounted for a substantial share of child deaths across CHAMPS sites. Reducing mortality will require preventing diarrhea and addressing key contributors such as malnutrition and HIV.

Identifiers

PMID40561131
PMCPMC12193650

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.